No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bendamustine Hydrochloride / adverse effects
-
Bendamustine Hydrochloride / therapeutic use
-
Cyclophosphamide / adverse effects
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / adverse effects
-
Doxorubicin / therapeutic use
-
Female
-
Humans
-
Infections / chemically induced
-
Lymphoma, B-Cell / complications
-
Lymphoma, B-Cell / drug therapy*
-
Male
-
Middle Aged
-
Neoplasms, Second Primary / chemically induced
-
Prednisone / adverse effects
-
Prednisone / therapeutic use
-
Rituximab / adverse effects
-
Rituximab / therapeutic use
-
Vincristine / adverse effects
-
Vincristine / therapeutic use
Substances
-
Rituximab
-
Vincristine
-
Doxorubicin
-
Cyclophosphamide
-
Bendamustine Hydrochloride
-
Prednisone